Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study

Clinical Drug Investigation

Volumn 27, Issue 9, 2007, Pages 623-632

  Payeras, Antonio Coca ^a   Sladek, Krzysztof ^b   Lembo, Giuseppe ^c   Alberici, Marco ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Vaccination Outpatient Clinic   (Poland)

^c IRCCS NEUROMED   (Italy)

^d CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CHLORTALIDONE; MANIDIPINE;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; AGED; ANKLE EDEMA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ECG ABNORMALITY; EDEMA; ELECTROCARDIOGRAM; FEMALE; FLUSHING; GLUCOSE BLOOD LEVEL; HEADACHE; HEART PALPITATION; HEART RATE VARIABILITY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; CHLORTHALIDONE; DIHYDROPYRIDINES; DIURETICS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548103549     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200727090-00004     Document Type: Article

References (32)

1. Franklin SS, Gustin 4th W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997; 96: 308-15
2. Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37: 869-74
3. Himmelmann A, Hedner T, Hansson L, et al. Isolated systolic hypertension: an important cardiovascular risk factor. Blood Press 1998; 7: 197-207
4. Kannel WB. Prevalence and implications of uncontrolled systolic hypertension. Drugs Aging 2003; 20: 277-86
5. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-64
6. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension: the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64
7. Liu L, Wang JG, Gong L, et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension: Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998; 16: 1823-9
8. Wang JG, Staessen JA, Gong L, et al. Chinese trial on isolated systolic hypertension in the elderly: Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 2000; 160: 211-20
9. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension: European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53
10. Guidelines Subcommittee of the World Health Organization: International Society of Hypertension (WHO-ISH) Mild Hypertension Liaison Committee. 1999 World Health Organization: International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-83
11. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). JAMA 2003; 289: 2560-72
12. Fogari R, Zoppi A, Corradi L, et al. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. J Hypertens 2000; 18: 1871-5
13. McKeage K, Scott LJ. Manidipine: a review of its use in the management of hypertension. Drugs 2004; 64 (17): 1923-40
14. Mugellini A, Rinaldi A, Zoppi A, et al. Effect of manidipine as compared to atenolol on platelet aggregation in elderly patients with isolated systolic hypertension and type II diabetes mellitus. J Cardiovasc Pharmacol 2005; 45: 310-3
15. Saku K, Zhang B, Hirata K, et al. Effects of manidipine and delapril on serum lipids, lipoproteins, and apolipoproteins in patients with mild to moderate essential hypertension: a randomized trial with one-year follow-up. Clin Ther 1992; 14: 813-20
16. Tomiyama H, Kimura Y, Sakuma Y, et al. Effects of an ACE inhibitor and a calcium channel blocker on cardiovascular autonomic nervous system and carotid distensibility in patients with mild to moderate hypertension. Am J Hypertens 1998; 11: 682-9
17. Mancia G, Omboni S, Agabiti-Rosei E, et al. Antihypertensive efficacy of manidipine and enalapril in hypertensive patients. J Cardiovasc Pharmacol 2000; 35: 926-31
18. Fogari R, Mugellini A, Zoppi A, et al. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. Eur J Clin Pharmacol 2005; 61: 483-90
19. Casiglia E, Mazza A, Tikhonoff V, et al. Therapeutic profile of manidipine and lercanidipine in hypertensive patients. Adv Ther 2004; 21: 357-69
20. Zanchetti A, Omboni S, La Commare P, et al. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol 2001; 38: 642-50
21. Fogari R, Zoppi A, Mugellini A, et al. Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives. Cardiovasc Drugs Ther 1999; 13: 243-8
22. Palatini P, Mugellini A, Spagnuolo V, et al. Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine, alone or in combination with a low-dose diuretic, in elderly patients with isolated systolic hypertension (ValSyst Study). Blood Press Monit 2004; 9: 91-7
23. Malacco E, Vari N, Capuano V, et al. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study. Clin Ther 2003; 25: 2765-80
24. Volpe M, Junren Z, Maxwell T, et al. Comparison of the blood pressure-lowering effects and tolerability of losartan and amlodipine-based regimens in patients with isolated systolic hypertension. Clin Ther 2003; 25: 1469-89
25. Mounier-Vehier C, Jaboureck O, Emeriau JP, et al. Randomized, comparative, double-blind study of amlodipine vs. nicardipine as a treatment of isolated systolic hypertension in the elderly. Fundam Clin Pharmacol 2002; 16: 537-44
26. Grimm Jr RH, Black H, Rowen R, et al. Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension. Am J Hypertens 2002; 15 (1 Pt 1): 31-6
27. Emeriau JP, Knauf H, Pujadas JO, et al. A comparison of indapamide SR 1.5mg with both amlodipine 5mg and hydrochlorothiazide 25mg in elderly hypertensive patients: a randomized double-blind controlled study. J Hypertens 2001; 19: 343-50
28. Webster J, Fowler G, Jeffers TA, et al. A comparison of amlodipine with enalapril in the treatment of isolated systolic hypertension. Br J Clin Pharmacol 1993; 35: 499-505
29. Pocock SJ, McCormack V, Gueyffier F, et al. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001; 323: 75-81
30. Grossman E, Messerli FH. Effect of calcium antagonists on sympathetic activity. Eur Heart J 1998; 19 Suppl. F: F27-31
31. Kannel WB, Kannel C, Paffenbarger Jr RS, et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-94
32. Palatini P, Thijs L, Staessen JA, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162: 2313-21